The effects of the calcium entry blocker nicar dipine on CBF. CMR02, and neurologic outcome fol lowing 10 min of complete cerebral ischemia were exam 684 differ between the groups throughout the study. In neuro logic outcome studies. 18 dogs were divided into three groups (of six dogs each): untreated; saline infusion only. posttreated; nicardipine as in CBF and CMR02 studies. pretreated; nicardipine 20 f-lg kg -I at 2 min preischemia and a subsequent infusion of 2 f-lg kg-I min -I from imme diately postischemia to 120 min postischemia. Nicardi pine treatment initiated either before or after ischemia failed to improve neurologic outcome at 48 h postisch emia. Thus. the increase of postischemic global CBF by nicardipine is not accompanied by neurologic re covery in a canine model of complete cerebral ischemia.
ined in dogs. In CBF and CMR02 studies. the CBF in the untreated group (seven dogs) and the nicardipine group (seven dogs; 20 f-lg kg-I at 30 min postischemia and a subsequent infusion of 2 f-lg kg-I min -I for 90 min) ini tially increased to 300-400% and then returned to pre ischemic values at 30 min postischemia. Thereafter the CBF in the untreated group significantly decreased to 50% of preischemic values for the following 90-min pe riod (hypoperfusion). while the CBF in the nicardipine group did not differ from preischemic values. The CMR02 in both groups decreased to �50-80% of pre ischemic values after 15 min postischemia and did not Recent animal studies suggest that postischemic hypoperfusion may be one of the important factors contributing to the ultimate neurological damage (Siesj6, 1981; Hossmann, 1982; White et aI., 1982) and the improvement of hypoperfusion may have beneficial effects on neurologic outcome (Siesj6, 1981; Hossmann, 1982; Steen et al.. 1983; White et a\., 1983a) . There has been accumulating evidence that some calcium entry blockers improve CBF and/or neurologic outcome after resuscitation. Steen et a\. (1983 Steen et a\. ( ,1984 reported that in a canine model nimodipine significantly increased CBF in the postischemic hypoperfusion period when it was given either before or after ischemia. Neurologic outcome was significantly improved only when the drug was given before ischemia. In their subse quent primate intensive care study (Steen et aI., 1985) , it was shown that neurologic outcome was significantly improved by nimodipine therapy initi ated following resuscitation. Other calcium entry blockers used in animal studies include lidoflazine and flunarizine. Lidoflazine was reported to im prove CBF in one study (White et aI., 1983b) but not in another (Dean et aI., 1983) . The former group (Winegar et aI., 1983) found that lidoflazine reduced the neurologic deficits after resuscitation. Vaagencs et al. (1983) reported the failure of lidoflazine to re duce neurologic deficits after asphyxial cardiac ar rest. However, they later (1984) reported the im provement of the neurologic outcome without CBF improvement after ventricular fibrillation. With flunarizine White et a\. (1982) found an improve ment of CBF, while Newberg et al. (1984) reported no beneficial effects on CBF and neurologic out come in dogs. These conflicting results regarding the postischemic CBF and neurologic outcome for the different calcium entry blockers led us to ex amine thc effects of another, nicardipine, which has been known as a potent cerebral vasodilator (Ya mamoto et al. , 1983 ) similar to nimodipine (Muller Schweinitzer and Neumann, 1983) . We found that the increase of CBF after resuscitation with nicar dipine was not accompanied by the improvement of neurologic outcome in a canine model.
MATERIALS AND METHODS
Two series of studies were performed in 32 unpremedi cated dogs subjected to a 10-min period of complete cere bral ischemia produced by temporary cross-clamping of the aorta and the venae cavae. Fourteen dogs were sub jected to CBF and CMR02 studies and 18 dogs to neuro logic outcome studies.
CBF and CMROz studies
For surgical preparation dogs were anesthetized with halothane (1-2%)-N20 (60'IG) and mechanically venti lated with endotracheal intubation and a Harvard pump.
Cannulas were inserted into the inferior vena cava and descending aorta through the femoral vein and artery for administration of drugs and fluid and for blood sampling and pressure monitoring. Through a right -sided thora cotomy, umbilical tapes were placed around the as cending aorta, inferior vena cava. and superior vena cava just above the azygos vein. For the measurement of CBF. the sagittal sinus was cannulated following heparinization (2 mg kg-I, then 0.5 mg kg-I h-I), as originally described by Michenfelder et al. (1968) and subsequently modified by Oshita et al. (1979) . Drained blood was returned to the external jugular vein through the draining cannula. An electromagnetic flowmeter probe (lumen diameter 3 mm) was incorporated I cm away from the draining portion of the sinus. To ensure exact measurements the flowmeter (Nihon Koden MF-I 6) incorporated a nonocclusive zero and a 3-s time constant. In addition, the flowmeter was frequently calibrated by direct timed measurements of the sagittal sinus blood flow. The average draining per centage (41 ± 1% of the total brain weight) in our recent study with the same technique (Miyauchi et aI., 1985) 
Neurologic outcome studies
In 18 dogs for neurologic outcome studies, anesthesia and surgical preparation were the same as in the CBF and CMR02 studies except for CBF measurement. Whole procedures were performed under sterile conditions. The untreated group (six dogs) received saline infusion and the posttreated group (six dogs) received nicardipine as in the CBF and CMR02 studies. Dogs for these groups were randomized. Another six dogs were added later (see Dis cussion) to examine the effect of pretreatment with nicar dipine (pretreated group). In this group nicardipine 20 fLg kg-I was given 2 min before ischemia, followed by an infusion at a constant rate of 2 fLg kg-I min -I for 120 min initiated immediately after resuscitation. The technique producing ischemia and ischemia duration were exactly the same as in the CBF and CMR02 studies. Epinephrine was given in 9 of 18 dogs and averaged 4 ± 1 fLg kg-I.
Following resuscitation, thoracotomy was closed after ensuring that there was no bleeding in the thoracic cavity; the lung was adequately inflated by manual hyperinfla tion, and then 0.2% halothane was discontinued. Ventila tion was controlled until spontaneous ventilation was deemed adequate (PaC02 < 45 mm Hg). The average time of extubation was 260 ± 40, 220 ± 30, and 350 ± 70 min in the un-, post-, and pretreated groups, respectively. 
RESULTS

CBF and CMR02 studies
Physiologic variables are shown in Ta ble 1. There was no significant difference in preischemic values of MABP between the groups. During postischemia the MABP was maintained at the preischemic level shortly after the release of vascular occlusion. In the untreated group, postischemic MABP was not significantly different from the preischemic level, while in the nicardipine group, the MABP was sig nificantly decreased with nicardipine administra tion and significantly lower than that of the un treated group at 60-120 min. There were no signifi cant differences in Pao2 and Paco2, or pH at any time between the groups. During an early resuscita tion period, Paco2 significantly increased to 60 mm Hg and then returned to preischemic values at 30 min in both groups. Arterial pH decreased maxi mally at 3 min postischemia and tended to recover to preischemic values in both groups; but in the ni cardipine group, it remained decreased even at 60 and 120 min. Esophageal temperature was main tained at 36.8 ± 0. 2 and 37.1 ± 0.2°C and hemo-globin at 14 ± 0. 5 and 13 ± 0.8 g dl-1 in the un treated and nicardipine groups, respectively.
There were no significant differences in preisch emic values of CBF, CMR02, CVR, and partial pressure of oxygen in the sagittal sinus blood (Psso2) between the two groups. Changes in CBF and CMR02 are illustrated in Fig. 1 . After resusci tation the CBF increased to 300-400% of pre ischemic values (hyperemia). This hyperemia lasted � 10 min in both groups. At 20-30 min post ischemia, the CBF returned to preischemic values, thereafter it decreased to �50% of preischemic values in the untreated group (hypoperfusion), while in the nicardipine group CBF did not de crease below postischemic values at any time post ischemia. The CBF values in the nicardipine group were significantly higher than those of the un treated group. The CVR significantly decreased during the hyperemic period. Thereafter in the un treated group the CVR significantly increased with time, while in the nicardipine group it did not in crease and was significantly lower than in the un treated group. The CMR02 decreased to 50% of preischemic values at 15 min postischemia and then tended to increase to 80% in both groups. Psso2 sig nificantly increased during the hyperemic period; then it gradually decreased below preischemic values in the untreated group while in the nicardi pine group it did not decrease and was significantly higher than in the untreated group.
EEG during the preischemic period consisted of predominantly 15-to 20-Hz waves occasionally in termingled with 6-to 8-Hz waves. After the occlu sion of the aorta and the venae cavae, EEG became isoelectric at 26 ± 5 and 29 ± 7 s and it reappeared at 16 ± 2 and 17 ± 3 min postischemia in the un- CBF did not decrease below the preischemic value and was maintained higher than that of the untreated group after 45 min postischemia. There was no significant difference in CMR02 at any time between the two groups.
treated and nicardipine groups, respectively. There after EEG showed predominantly 2-to 6-Hz waves intermingled with sporadic 8-to 10-Hz waves, though there were individual variations. There were no significant differences in EEG grade be tween the two groups at any time throughout the study.
Neurologic outcome studies
Physiologic variables in the pre-and postisch emic periods in three groups are summarized in Table 2 . The values preischemia and 60 and 120 min postischemia in the untreated and posttreated groups are comparable with those of the CBF and CMR02 studies. The MABPs of the treated groups were lower than in the untreated group but were maintained above 70 mm Hg. Pao2 after extubation was maintained above 70 mm Hg in individual dogs. EEG became isoelectric at 35 ± 7, 36 ± 7, and 44 ± 18 s after the vascular occlusion, and it reappeared at 23 ± 3, 24 ± 8, 18 ± 4 min after resuscitation in the untreated, posttreated, and pre treated groups, respectively. These values were not significantly different either from those of the CBF and CMR02 studies or among the groups in the neurologic outcome studies. Neurologic status 48 h after 10-min ischemia is summarized in Ta ble 3. No significant difference was observed among the groups. In dogs that died before 48-h evaluation, there were no apparent cardiopulmonary complica tions that might be attributed to the cause of death, except for one dog in the untreated group that ex hibited possible neurogenic pulmonary edema and died at 18 h postischemia. Despite the vigorous ex ternal cooling, one dog in the untreated group and two dogs in the posttreated group exhibited hy perthermia of 40°C and their outcomes were all in Grade 3. There was no correlation between body temperature and neurologic outcome in individual dogs.
DISCUSSION
The present study shows that nicardipine in creases CBF after resuscitation, but has neither protective nor ameliorative effects on neurologic outcome following 10-min complete cerebral isch emia in the dog. The magnitude and duration of hy peremia observed immediately after resuscitation are compatible with those of previous studies (Siesj6, 1981; Steen et aI., 1978 Steen et aI., ,1983 Steen et aI., , 1984 Hoss mann, 1982) . During subsequent hypoperfusion the CBF in the nicardipine group was significantly higher than that in the untreated group throughout the study. The reduction in CMR02 to 50% during the early stage of resuscitation and its subsequent return to �80% at 120 min postischemia suggest that cerebral oxygen utilization partially recovers with time after a hypoxic insult, irrespective of whether nicardipine is used or not. Higher CBF in the nicardipine group resulted in higher Psso2 during the postischemic period, indicating improve ment of overall cerebral oxygen supply with the drug. However, higher CBF induced by nicardipine was not accompanied by higher CMR02. This sug gests that the metabolic rate after resuscitation is determined by factors other than global blood flow. No significant difference in EEG between both groups indicated that the nicardipine-induced in crease in CBF after resuscitation did not provide better maintenance of neural function (judged by EEG) at least during 120 min after resuscitation.
U sing the same model as in the present study, Steen et al. (1983) reported that nimodipine when given 2 min before ischemia and followed by con tinuous infusion for 2 h postischemia improved CBF as well as neurologic outcome. They sug gested that the protective effect of nimodipine may be due to the better maintenance of CBF during the postischemic period. Their subsequent study found that when nimodipine was given 2 min after the ischemic period, CBF was improved, as seen in our study, whereas the effect on neurologic recovery was equivocal (Steen et aI., 1984) . This is one of the reasons why we later added the pretreated group in the neurologic outcome studies, yet we found no protective effect of nicardipine.
Regarding the relationship between CMR02 after resuscitation and neurologic outcome, the findings of Steen et al. (1983 Steen et al. ( ,1984 are slightly complicated. They reported that pretreatment with nimodipine improved CBF and neurologic outcome without significant improvement of CMR02 in one study (Steen et aI., 1983) , while with posttreatment neu rologic outcome was equivocal despite the signifi cant improvement of CMR02 and CBF (Steen et aI. , 1984) . From these results it may be difficult to correlate CMR02 and improvement of outcome.
Our results rather indicate that the increase in CBF is not necessarily accompanied by the increase in CMR02 and the improvement of outcome.
The absolute values of CBF after resuscitation in our nicardipine group are very similar to those of the nimodipine groups reported by Steen et al. (1983 Steen et al. ( , 1984 , though there are the differences in chemical structure, doses, and timing of adminis tration of the calcium entry blocker used. As suming that the increase in CBF induced by nicar dipine in CBF and CMR02 studies occurred in the neurologic outcome studies, one possible explana tion for the difference in neurologic outcome be tween nicardipine pretreatment in our study and ni modipine pretreatment by Steen et at. (1983) is that the nicardipine-induced increase in CBF may be different from the nimodipine-induced one in its re gional distribution. Smith et al. (1983) , using an au to radiographic technique, found nimodipine pre treatment increased postischemic CBF in rats sub jected to incomplete ischemia. However, the flow enhancement was regionally heterogeneous, some times resulting in zones of gross hypoperfusion and overt hyperperfusion within the same structures. They suggested that overall CBF improvement does not necessarily imply a CBF improvement in all cerebral structures. Failure to demonstrate neu rologic improvement with nicardipine in the present study might be due to more adverse CBF redistri bution compared with CBF redistribution with ni modipine. A similar explanation can be given for the discrepancy between our work and the reports by White et al. (l983b) and Winegar et al. (1983) , who observed improvement of CBF and neurologic function by lidoflazine, though their method for CBF measurement has not been validated. How ever, work regarding the effect of lidoflazine is con flicting, since Dean et al. (1983) reported no im provement of postischemic CBF with lidotlazine given 5 min after resuscitation and Vaagenes et al. (1983) reported the failure of lidoflazine to reduce neurologic deficits after asphyxial cardiac arrest. In this study, no improvement of neurologic outcome indicates that an increase in CBF per se does not necessarily result in better neurologic outcome.
Although Steen et al. (1983) attributed the im provement of neurologic outcome to the improve ment of CBF with nimodipine, they also state that other effects that were not looked for cannot be ruled out. Mechanisms other than CBF improve ment for the improvement of neurologic outcome may include a direct effect of calcium entry blockers on neurons, such as a reduction in the cal cium loading of brain cell, opposing the activation of phospholipase, which releases free fatty acids (Siesjo, 198 1; White et aI., 1983a) . Vaagenes et al. (1984) reported improved neurologic outcome with lidoflazine given 5 min after the ischemic insult (ventricular fibrillation) and at 8 and 16 h despite the fact that their preliminary observation failed to dem onstrate any improvement in postischemic hy poperfusion. The authors proposed that the effect of lidoflazine was due to a direct effect on neurons, though the direct evidence remains to be docu mented.
The systemic effect of a specific calcium entry blocker and/or duration of therapy are other factors to be considered. For example, it has been reported that flunarizine failed to improve postischemic CBF, and neurologic outcome was even worse owing to its cardiodepressive effect (Newberg et aI., 1984) . Unlike flunarizine, only mild hypoten sion was observed with nicardipine during its ad ministration, so that cardiovascular effect does not seem to have contributed to the final outcome in our study. Using a neck tourniquet ischemia model in primates, Steen et al. (1985) reported that the im provement of neurologic outcome by nimodipine treatment commenced 5 min after 17 min of com plete ischemia when it was evaluated after intensive care for 96 h. Vaagenes et al. (1984) stated that short-term (24-48 h) recovery models are unreli able because of the high incidence of secondary de-terioration 48-96 h in the control group. Consid ering the poor outcome at 48 h in both the untreated and treated groups in our present study, it is un likely that long-term follow-up over 48 h would produce results different from the present ones. However, it must be added that the duration of ni cardipine treatment (up until 120 min postischemia in the present study) might have been insufficient because CBF may decrease after the cessation of nicardipine therapy, which might affect the final outcome.
In summary nicardipine prevents postischemic hypoperfusion, as does nimodipine, but does not improve neurologic outcome irrespective of whether it is used before or after the insult in a ca nine model. This suggests that the increase in global flow after resuscitation is not necessarily ac companied by the improvement of neurologic out come.
